Home-based intensive motor telerehabilitation with MindMotion GO for post-stroke arm weakness
Intensive Motor Rehabilitation of Stroke Patients: Evaluation of a Telerehabilitation Program
This will test whether a 12-week home telerehabilitation program using the MindMotion GO device improves arm motor recovery in people after a stroke.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 51 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Saint-Genis-Laval, Lyon) |
| Trial ID | NCT07254195 on ClinicalTrials.gov |
What this trial studies
This single-center randomized controlled trial will randomize sub-acute and chronic stroke patients to a 12-week home-based telerehabilitation program using the MindMotion GO device in addition to standard care, delivering 300 minutes per week of active therapy. The program combines one synchronous weekly session with a therapist and multiple asynchronous autonomous sessions, with remote planning and monitoring. It is integrated into the post-stroke care pathway to ease the transition from hospital to home without prolonging hospitalization or increasing face-to-face visits. The trial will measure feasibility, adherence, and motor function outcomes compared with standard care.
Who should consider this trial
Good fit: Ideal candidates are adults more than 30 days after a first ischemic or hemorrhagic stroke with residual upper-limb motor deficits who can sit unaided, follow device instructions, and have home internet, a smartphone, and a Full HD screen/TV with HDMI.
Not a fit: Patients with prior stroke, other neurological disorders, uncontrolled epilepsy, significant cardiac limitations, severe cognitive or psychiatric impairment, disabling pain, or without the required home technology are unlikely to benefit.
Why it matters
Potential benefit: If successful, patients could gain improved arm function and greater access to intensive rehabilitation at home, reducing long-term disability.
How similar studies have performed: Previous telerehabilitation studies have shown effectiveness comparable to in-person clinical rehabilitation, though device-specific evidence for MindMotion GO is still being established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized for a first ischemic or hemorrhagic stroke * Stroke occurrence more than 30 days prior * Presenting motor deficits affecting the upper limb, with or without involvement of the lower limb * Able to follow the instructions of the home program using the MindMotion GO device * Having at home an accessible email address, an Internet connection with password, a smartphone, a screen or TV with HDMI input (Full HD 1080p resolution), and a free space of approximately 1 m x 2.5 m in front of the screen * Ability to sit without assistance * Patient agreeing to participate in the study by signing an informed consent form * Affiliated with, or entitled to, a social security scheme Exclusion Criteria: History of stroke * Neurological pathology other than stroke * Patient with uncontrolled epilepsy or seizure disorder * Cardiac disease limiting exercise * Pain limiting rehabilitation dose * Major comprehension problems or severe psychiatric and/or cognitive disorders that could compromise understanding of the protocol and the smooth running of the study. * Uncorrected hearing or visual deficits * Severe apraxia * Severe memory impairment * Severe unilateral spatial neglect * Total plegia of affected limb * Pregnant, parturient or breast-feeding women * Persons deprived of their liberty by judicial or administrative decision * Persons admitted to a health or social institution for purposes other than research * Adults under legal protection (guardianship, curatorship) * Subjects participating in other intervention research.
Where this trial is running
Saint-Genis-Laval, Lyon
- Hopital Henry Gabrielle — Saint-Genis-Laval, Lyon, France (Recruiting)
Study contacts
- Study coordinator: Jacques LUAUTÉ, MD
- Email: Jacques.luaute@chu-lyon.fr
- Phone: 4 78 86 50 64
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.